{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:10:38Z","timestamp":1788588638978,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.hrthm.2020.05.043","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T01:22:02Z","timestamp":1591492922000},"page":"1944-1950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7393-1514","authenticated-orcid":false,"given":"Riccardo","family":"Vio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Bozzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rivezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loira","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Migliore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Bertaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Iliceto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Calore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.05.043_bib1","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2018.08.2182","article-title":"Cardiac phenotypes in hereditary muscle disorders: JACC state-of-the-art review","volume":"72","author":"Arbustini","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ijcard.2015.03.069","article-title":"Myotonic dystrophy and the heart: a systematic review of evaluation and management","volume":"184","author":"Lau","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib3","first-page":"751","article-title":"Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1","volume":"38","author":"Wahbi","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.05.043_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/europace\/euq423","article-title":"Long-term follow-up of patients with myotonic dystrophy: an electrocardiogram every year is not necessary","volume":"13","author":"Brembilla-Perrot","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.05.043_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jelectrocard.2012.02.003","article-title":"Arrhythmia-related workup in hereditary myopathies","volume":"45","author":"Finsterer","year":"2012","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.1992.tb05103.x","article-title":"Treatment of myotonia with antiarrhythmic drugs","volume":"86","author":"Kwieci\u0144ski","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.hrthm.2020.05.043_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1651-2227.1992.tb12271.x","article-title":"Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen\u2019s disease) successfully treated with mexiletine","volume":"81","author":"Ceccarelli","year":"1992","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.hrthm.2020.05.043_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mus.880170710","article-title":"Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy","volume":"17","author":"Jackson","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hrthm.2020.05.043_bib9","first-page":"665","article-title":"[Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine]","volume":"139","author":"Pouget","year":"1983","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.hrthm.2020.05.043_bib10","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.0b013e3181dc1a3a","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"74","author":"Logigian","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2020.05.043_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00005344-198107000-00009","article-title":"Effects of antiarrhythmic drugs on AV nodal and intraventricular conduction as assessed in the isolated, blood-perfused AV node preparation of the dog","volume":"3","author":"Satoh","year":"1981","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/WNL.56.3.336","article-title":"Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy","volume":"56","author":"Mathieu","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2020.05.043_bib13","first-page":"69","article-title":"Electrophysiological basis for a rationale approach to antidysrhythmic drug therapy","volume":"9","author":"Williams","year":"1974","journal-title":"Adv Drug Res"},{"key":"10.1016\/j.hrthm.2020.05.043_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/WNL.0b013e3181fe72d7","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"76","author":"Groh","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2020.05.043_bib15","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1","volume":"358","author":"Groh","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.05.043_bib16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0735-1097(02)02339-2","article-title":"Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study","volume":"40","author":"Lazarus","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2010.02.029","article-title":"Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices","volume":"150","author":"Laurent","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.2012.346","article-title":"Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease","volume":"307","author":"Wahbi","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2020.05.043_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijcard.2014.02.001","article-title":"Insufficiency of electrocardiogram alone in predicting infrahisian abnormalities in patients with type 1 myotonic dystrophy","volume":"172","author":"Sim\u00e9on","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib20","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1161\/CIR.0000000000000526","article-title":"Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association","volume":"136","author":"Feingold","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.05.043_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12968-014-0059-z","article-title":"Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study","volume":"16","author":"Petri","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hrthm.2020.05.043_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1532-429X-14-48","article-title":"Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study","volume":"14","author":"Hermans","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hrthm.2020.05.043_bib23","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/heartjnl-2015-308517","article-title":"Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy","volume":"102","author":"Choudhary","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2020.05.043_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCIMAGING.110.960740","article-title":"Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations","volume":"4","author":"Verhaert","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2020.05.043_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2016.4145","article-title":"Left ventricular dysfunction and conduction disturbances in patients with myotonic muscular dystrophy type I and II","volume":"2","author":"Tanawuttiwat","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib26","doi-asserted-by":"crossref","first-page":"e009100","DOI":"10.1161\/CIRCIMAGING.119.009100","article-title":"Comprehensive cardiac magnetic resonance for assessment of cardiac involvement in myotonic muscular dystrophy type 1 and 2 without known cardiovascular disease","volume":"12","author":"Luetkens","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2020.05.043_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12968-019-0535-6","article-title":"Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality","volume":"21","author":"Cardona","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hrthm.2020.05.043_bib28","first-page":"e23","article-title":"Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy","volume":"25","author":"Breton","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00415-002-0692-6","article-title":"Cardiac involvement and CTG expansion in myotonic dystrophy","volume":"249","author":"Merlevede","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1540-8167.2011.02200.x","article-title":"Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population","volume":"22","author":"Bhakta","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib31","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.05.043_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/jce.13431","article-title":"Mexiletine or catheter ablation after amiodarone failure in the VANISH trial","volume":"29","author":"Deyell","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib33","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy","volume":"92","author":"Schwartz","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.05.043_bib34","doi-asserted-by":"crossref","first-page":"e007280","DOI":"10.1161\/CIRCEP.118.007280","article-title":"Mexiletine shortens the QT interval in patients with potassium channel-mediated type 2 long QT syndrome","volume":"12","author":"Bos","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.05.043_bib35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/eurheartj\/ehaa041","article-title":"Continued misuse of orphan drug legislation: a life-threatening risk of mexiletine","volume":"41","author":"Postema","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120305464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120305464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:52:21Z","timestamp":1761547941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120305464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1547527120305464"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.043","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}